Filtered By:
Specialty: Urology & Nephrology
Management: Food and Drug Administration (FDA)

This page shows you your search results in order of date.

Order by Relevance | Date

Total 3 results found since Jan 2013.

Clinical Pharmacology of Oral Anticoagulants in Patients with Kidney Disease.
This article summarizes the clinical pharmacology of these drugs and identifies knowledge gaps in the literature related to their use. PMID: 29802125 [PubMed - as supplied by publisher]
Source: Clinical Journal of the American Society of Nephrology : CJASN - May 25, 2018 Category: Urology & Nephrology Authors: Jain N, Reilly RF Tags: Clin J Am Soc Nephrol Source Type: research

Pd50-03 cardiovascular events and prostate cancer diagnoses in men treated with testosterone replacement therapy
The U.S. Food and Drug Administration recently issued a caution that testosterone replacement therapy (TRT) may increase the risk of heart attack and stroke. This was based primarily on studies that had short follow-up and limited duration of treatment. We sought to determine the association of the long-term use of TRT and rates of cardiovascular events, prostate cancer, and overall mortality.
Source: The Journal of Urology - March 28, 2016 Category: Urology & Nephrology Authors: Christopher Wallis, Kirk Lo, Yuna Lee, Yonah Krakowsky, Alaina Garbens, Raj Satkunasivam, Sender Herschorn, Ronald Kodama, Patrick Cheung, Steven Narod, Robert Nam Tags: Sexual Function/Dysfunction: Medical, Hormonal & Non-surgical Therapy II Source Type: research

Re: Testosterone Products: Drug Safety Communication - FDA Cautions about Using Testosterone Products for Low Testosterone due to Aging; Requires Labeling Change to Inform of Possible Increased Risk of Heart Attack and Stroke
U.S. Food and Drug Administration
Source: The Journal of Urology - June 17, 2015 Category: Urology & Nephrology Authors: Allen D. Seftel Tags: Urological Survey Source Type: research